| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 28, 2025 | Mar 3, 2025 | Salesforce, Inc. | Director | Buy | 90.0 | +1,695 | 4.06% | ✗ | $499.4K |
| Feb 18, 2025 | Feb 20, 2025 | HONEYWELL INTERNATIONAL INC | Director | Sell | 20.0 | -2,124 | -13.89% | ✗ | $437.6K |
| Nov 19, 2024 | Nov 21, 2024 | Vertiv Holdings Co | Director | Sell | 7.5 | -5,000 | -50.00% | ✓ | $673.5K |
| Nov 3, 2023 | Nov 7, 2023 | HONEYWELL INTERNATIONAL INC | Director | Sell | 20.0 | -1,927 | -14.05% | ✗ | $364K |
| Feb 6, 2019 | Feb 8, 2019 | GILEAD SCIENCES, INC. | CFO | Sell | 97.5 | +16,047 | 93.51% | ✗ | $380.5K |
| Feb 21, 2018 | Mar 2, 2018 | GILEAD SCIENCES, INC. | CFO | Sell | 20.0 | -5,000 | -3.92% | ✗ | $401.6K |
| Feb 15, 2018 | Feb 23, 2018 | GILEAD SCIENCES, INC. | CFO | Sell | 97.5 | +14,487 | 150.87% | ✗ | $459.1K |
| Sep 7, 2017 | Sep 11, 2017 | GILEAD SCIENCES, INC. | CFO | Sell | 5.0 | -51,820 | -31.43% | ✓ | $4.4M |
| Feb 15, 2017 | Feb 21, 2017 | GILEAD SCIENCES, INC. | CFO | Sell | 75.0 | +202 | 0.95% | ✗ | $549.4K |